Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AG1549 + Viracept + Combivir in Treatment-Naive HIV
NCT00004999Phase 2Suspended
- Sponsor
- Agouron Pharmaceuticals
- Start
- Aug 1999
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Capravirine Arm with Placebo Arm (2 arms). Started Aug 1999; status: suspended.
02
Drugs
capravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00004999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004999.